Sign up to our newsletter Subscribe
An Analysis of NICE’s Optimised Decisions from 2015 to 2024

Sign up to our newsletter Subscribe
A new OHE Research Paper has just been published on the topic of uncertainty and risk in health technology assessment (HTA) decision making. The report is concerned with uncertainty as it affects the cost effectiveness aspects of HTA. A new…
A new OHE Research Paper has just been published on the topic of uncertainty and risk in health technology assessment (HTA) decision making. The report is concerned with uncertainty as it affects the cost effectiveness aspects of HTA.
A new OHE Research Paper has just been published on the topic of uncertainty and risk in health technology assessment (HTA) decision making.
The quality of decision-making in key public sector bodies dealing with resource allocation is a major determinant of their efficiency. One of the most difficult and contentious areas of decision-making is the way that uncertainty is dealt with.
This report is concerned with uncertainty as it affects the cost effectiveness aspects of HTA.
It includes a review of the policy documents governing cost benefit analysis and cost effectiveness analysis in respect of HTA in England and Wales, and the results of interviews with former decision makers at the National Institute for Health and Care Excellence (NICE).
Uncertainty has a number of definitions, and components, which are explored. The first interpretation derives from risk aversion. We explore several factors that contribute to risk aversion and find limited reasons for a NICE Appraisal Committee to be risk averse.
The second view of uncertainty is described in terms of variability in the probabilities and outcomes associated with people receiving each treatment option. This is the main way that a NICE Appraisal Committee considers uncertainty in the context of economic evaluation.
The paper finds that:
Download the full paper here.
For more information please contact Adrian Towse at OHE.
An error has occurred, please try again later.